Guru Ownership Trend
Guru Analysis for ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. (SPRY), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $8.94 M.
Top institutional holders include Daniel Loeb and Chuck Royce.
Institutional sentiment is currently Bullish. This is evidenced by a $2.54 M net inflow during the quarter.
Recent activity highlights Cliff Asness who opened a new position. Conversely, Chuck Royce reduced exposure by 73.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for ARS Pharmaceuticals, Inc. (SPRY)
Major holders include Daniel Loeb ($8.03 M), Chuck Royce ($433,813), Cliff Asness ($207,791). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.08 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.54 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited SPRY. The total reported sell value was $1.23 M.
Yes, 1 managers opened new positions in SPRY, and 1 increased their existing holdings. The total reported buy value was $3.77 M.